The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Therefore, P. aeruginosa can quickly develop resistance to various antibiotics, including aminoglycosides, quinolones, and β-lactams.224”
From Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics (2022) · cites this paper as [224]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of Drug Access to Bacterial Targets: Permeability Barriers and Active Efflux
Nikaido, H. (1994) · Science · doi:10.1126/science.8153625 · Cited by 1,540
High Frequency of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Lung Infection
Oliver, A., Cantón, R., Campo, P., Baquero, F., & Blázquez, J. (2000) · Science · doi:10.1126/science.288.5469.1251 · Cited by 1,465
Cationic peptides: a new source of antibiotics
Hancock, R. E. W., & Lehrer, R. (1998) · Trends in Biotechnology · doi:10.1016/s0167-7799(97)01156-6 · Cited by 1,336
Self-citationIntermittent Administration of Inhaled Tobramycin in Patients with Cystic Fibrosis
Ramsey, B. W., Pepe, M. S., Quan, J. M., Otto, K. L., Montgomery, A. B., Williams-Warren, J., Vasiljev-K, M., Borowitz, D., Bowman, C. M., Marshall, B. C., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901073400104 · Cited by 1,300
A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis
Stover, C. K., Warrener, P., VanDevanter, D. R., Sherman, D. R., Arain, T. M., Langhorne, M. H., Anderson, S. W., Towell, J. A., Yuan, Y., McMurray, D. N., et al. (2000) · Nature · doi:10.1038/35016103 · Cited by 1,034
Specific Lipopolysaccharide Found in Cystic Fibrosis Airway Pseudomonas aeruginosa
Ernst, R. K., Yi, E. C., Guo, L., Lim, K. B., Burns, J. L., Hackett, M., & Miller, S. I. (1999) · Science · doi:10.1126/science.286.5444.1561 · Cited by 484
A Dose-Response Study of Antibiotic Resistance in Pseudomonas aeruginosa Biofilms
Brooun, A., Liu, S., & Lewis, K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.640-646.2000 · Cited by 473
Aires, J. R., Köhler, T., Nikaido, H., & Plésiat, P. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.11.2624 · Cited by 391
The bacterial outer membrane as a drug barrier
HANCOCK, R. (1997) · Trends in Microbiology · doi:10.1016/s0966-842x(97)81773-8 · Cited by 388
Self-citationAntibiotic Resistance Caused by Gram‐Negative Multidrug Efflux Pumps
Nikaido, H. (1998) · Clinical Infectious Diseases · doi:10.1086/514920 · Cited by 348
Ziha-Zarifi, I., Llanes, C., Köhler, T., Pechere, J.-C., & Plesiat, P. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.2.287 · Cited by 276
Köhler, T., Michea-Hamzehpour, M., Epp, S. F., & Pechere, J.-C. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.2.424 · Cited by 268
Renau, T. E., Léger, R., Flamme, E. M., Sangalang, J., She, M. W., Yen, R., Gannon, C. L., Griffith, D., Chamberland, S., Lomovskaya, O., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9904598 · Cited by 260
THE BACTERIA: A TREATISE ON STRUCTURE AND FUNCTION
(1990) · Molecular Basis of Bacterial Pathogenesis · doi:10.1016/b978-0-12-307211-5.50001-5 · Cited by 244
Westbrock-Wadman, S., Sherman, D. R., Hickey, M. J., Coulter, S. N., Zhu, Y. Q., Warrener, P., Nguyen, L. Y., Shawar, R. M., Folger, K. R., & Stover, C. K. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.12.2975 · Cited by 242
Jalal, S., Ciofu, O., Høiby, N., Gotoh, N., & Wretlind, B. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.710-712.2000 · Cited by 236
Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum.
Mendelman, P. M., Smith, A. L., Lévy, J., Weber, A., Ramsey, B. W., & Davis, R. L. (1985) · PubMed · doi:10.1164/arrd.1985.132.4.761 · Cited by 216
Ochs, M. M., McCusker, M. P., Bains, M., & Hancock, R. E. W. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1085 · Cited by 214
Self-citationMacfarlane, E. L. A., Kwasnicka, A., & Hancock, R. E. W. (2000) · Microbiology · doi:10.1099/00221287-146-10-2543 · Cited by 209
Self-citationNEBULISED COLOMYCIN FOR EARLY PSEUDOMONAS COLONISATION IN CYSTIC FIBROSIS
Littlewood, J. M., Miller, M. G., Ghoneim, A. T., & Ramsden, C. H. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92222-6 · Cited by 203
Biological Properties of Structurally Related α-Helical Cationic Antimicrobial Peptides
Scott, M. G., Yan, H., & Hancock, R. E. W. (1999) · Infection and Immunity · doi:10.1128/.67.4.2005-2009.1999 · Cited by 189
Self-citationPseudomonas aeruginosa : infections and treatment
Baltch, A. L., & Smith, R. P. (1994) · Marcel Dekker eBooks · Cited by 159
Laraki, N., Galleni, M., Thamm, I., Riccio, M. L., Amicosante, G., Frère, J.-M., & Rossolini, G. M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.4.890 · Cited by 158
Antibiotic Pharmacokinetics in Cystic Fibrosis
de Groot, R., & Smith, A. L. (1987) · Clinical Pharmacokinetics · doi:10.2165/00003088-198713040-00002 · Cited by 157
Influence of Proline Residues on the Antibacterial and Synergistic Activities of α-Helical Peptides
Zhang, L., Benz, R., & Hancock, R. E. W. (1999) · Biochemistry · doi:10.1021/bi9904104 · Cited by 145
Self-citationPseudomonas aeruginosa as an Opportunistic Pathogen
Campa, M., Bendinelli, M., & Friedman, H. (1993) · Infectious agents and pathogenesis · doi:10.1007/978-1-4615-3036-7 · Cited by 141
Type II Topoisomerase Mutations in Ciprofloxacin-Resistant Strains of Pseudomonas aeruginosa
Mouneimné, H., Robert, J., Jarlier, V., & Cambau, E. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.1.62 · Cited by 134
Thomassen, M. J., Demko, C. A., Boxerbaum, B., Stern, R. C., & Kuchenbrod, P. J. (1979) · The Journal of Infectious Diseases · doi:10.1093/infdis/140.6.873 · Cited by 133
The OprB porin plays a central role in carbohydrate uptake in Pseudomonas aeruginosa
Wylie, J., & Worobec, E. A. (1995) · Journal of Bacteriology · doi:10.1128/jb.177.11.3021-3026.1995 · Cited by 121
The Bacteria: A TREATISE ON STRUCTURE AND FUNCTION
GUNSALUS, I. C., Ornston, L. N., Sokatch, J. R., & Stanier, R. Y. (1985) · Elsevier eBooks · doi:10.1016/b978-0-12-307208-5.50005-2 · Cited by 114
Masuda, N., Gotoh, N., Ishii, C., Sakagawa, E., Ohya, S., & Nishino, T. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.2.400 · Cited by 114
Tateda, K., Ishii, Y., Matsumoto, T., Furuya, N., Nagashima, M., Matsunaga, T., Ohno, A., Miyazaki, S., & Yamaguchi, K. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.10.2271 · Cited by 114
Bellido, F., Martin, N., Siehnel, R., & Hancock, R. E. W. (1992) · Journal of Bacteriology · doi:10.1128/jb.174.16.5196-5203.1992 · Cited by 107
Self-citationLevy, J., Smith, A. L., Kenny, M. A., Ramsey, B. W., & Schoenknecht, F. D. (1983) · The Journal of Infectious Diseases · doi:10.1093/infdis/148.6.1069 · Cited by 99
Huang, H., & Hancock, R. E. W. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.24.7793-7800.1993 · Cited by 97
Self-citationZhao, Q., Li, X.-Z., Srikumar, R., & Poole, K. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.7.1682 · Cited by 89
Nakae, T., Nakajima, A., Ono, T., Saito, K., & Hiroshi Yoneyama, C. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1301 · Cited by 88
Huang, H., & Hancock, R. E. W. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.11.3085-3090.1996 · Cited by 88
Self-citationPharmacokinetics of ciprofloxacin in cystic fibrosis
Davis, R. L., Koup, J. R., Williams‐Warren, J., et al. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.6.915 · Cited by 85
Outer Membrane Permeability of Pseudomonas aeruginosa
Nikaido, H., & HANCOCK, R. E. W. (1986) · Elsevier eBooks · doi:10.1016/b978-0-12-307210-8.50009-9 · Cited by 84
Self-citationINHALED ANTIBIOTICS IN CYSTIC FIBROSIS
Wall, M. A., Terry, A. B., Eisenberg, J. D., et al. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92428-5 · Cited by 82
Brinkman, F. S. L., Bains, M., & Hancock, R. E. W. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.18.5251-5255.2000 · Cited by 64
Self-citationThe therapeutic potential of cationic peptides
Hancock, R. E. W. (1998) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.7.2.167 · Cited by 52
Self-citationGerm, M., Yoshihara, E., Hiroshi Yoneyama, C., & Nakae, T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1045 · Cited by 52
Livermore, D. M. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.3.335 · Cited by 34
Aminoglycoside Adaptive Resistance
Karlowsky, J. A., Zelenitsky, S. A., & Zhanel, G. G. (1997) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1997.tb03063.x · Cited by 32
Martı́nez-Martı́nez, L., Pascual, Á., Conejo, M. C., Picabea, L., & Perea, E. J. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.2.397 · Cited by 30
Cited by
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies
Pang, Z., Raudonis, R., Glick, B. R., Lin, T.-J., & Cheng, Z. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.11.013 · Cited by 2,306
Qin, S., Xiao, W., Zhou, C., Pu, Q., Deng, X., Lan, L., Liang, H., Song, X., & Wu, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01056-1 · Cited by 1,703
Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence
Moradali, M. F., Ghods, S., & Rehm, B. H. A. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00039 · Cited by 1,537
The Epidemiology, Pathogenesis and Treatment of Pseudomonas aeruginosa Infections
Driscoll, J. A., Brody, S. L., & Kollef, M. H. (2007) · Drugs · doi:10.2165/00003495-200767030-00003 · Cited by 884
Human Host Defense Peptide LL-37 Prevents Bacterial Biofilm Formation
Overhage, J., Campisano, A., Bains, M., Torfs, E. C. W., Rehm, B. H. A., & Hancock, R. E. W. (2008) · Infection and Immunity · doi:10.1128/iai.00318-08 · Cited by 696
Self-citation
Metadata
- Authors
- Hancock, R. E. W., & Speert, D. P.
- Venue
- Drug Resistance Updates
- Publisher
- Elsevier BV
- Published
- 2000-08
- Volume
- 3
- Issue
- 4
- Pages
- 247-255
- ISSN
- 1368-7646 (ISSN-L)
- OpenAlex
- W2171452890
- Cited by
- 515
- References
- 47
- FWCI
- 3.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.